Objective Measurement of Cosmetic Outcomes of Breast Conserving Therapy Using BCCT.core.
- Author:
Tosol YU
1
;
Keun Yong EOM
;
Na Young JANG
;
Kyung Su KIM
;
Tae Ryool KOO
;
Jeanny KWON
;
Byoung Hyuck KIM
;
Eunyoung KANG
;
Sung Won KIM
;
Jae Sung KIM
;
In Ah KIM
Author Information
- Publication Type:Original Article
- Keywords: Breast Neoplasms; Breast conservative therapy; Quality of life; BCCT.core; Esthetics
- MeSH: Breast Neoplasms; Breast*; Esthetics; Humans; Informed Consent; Multivariate Analysis; Odds Ratio; Quality of Life; Tumor Burden
- From:Cancer Research and Treatment 2016;48(2):491-498
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study is to evaluate objective cosmetic outcomes and factors related to breast-conserving therapy (BCT) using the BCCT.core software. MATERIALS AND METHODS: Fifty-one patients who received BCT with informed consent were evaluated using the BCCT.core software. Patients were divided into two groups based on the BCCT score: excellent or good (n=42) vs. fair or poor (n=9). Analysis of clinical factors was performed to determine factors affecting cosmetic outcomes. RESULTS: The objective cosmetic outcome of BCT measured using the BCCT.core software was excellent in 10% of patients, good in 72%, and fair in 18%. None of the patients were classified as poor outcome. Tumor characteristics, systemic adjuvant therapy (chemotherapy and hormonal therapy), and radiation dose or energy of electron boost did not show correlation with the score measured by the BCCT.core program (p > 0.05). In univariate analysis, maximum dose within the breast (Dmax), width of tangential field, and excised tumor volume were smaller in patients with excellent or good by the BCCT.core compared to those with fair or poor (Dmax, 110.2±1.5% vs. 111.6±1.7%, p=0.019; width of tangential field, 8.0±1.1 cm vs. 8.6±0.7 cm, p=0.034; excised tumor volume, 64.0±35.8 cm3 vs. 95.3±54.4 cm3, p=0.067). In multivariate analysis, only Dmax was a significant factor for breast cosmetic outcome with a risk ratio of 1.697 (95% confidence interval, 1.006 to 2.863; p=0.047). CONCLUSION: Objective measurement of cosmetic outcome of BCT using the BCCT.core software was feasible. The cosmetic outcome of BCT may be affected by the maximum dose within the breast.
